Skip to content
Open access

Transformer-based decision support with CNN and ViT for prognostic risk stratification following adjuvant chemotherapy in high-grade glioma: a multicenter study.

Sep 2026 · Computer Methods and Programs in Biomedicine · Vol 288, pp. 109668 · 0 citations · 59 references
Medicine

TL;DR

This approach demonstrates robust, non-invasive performance in stratifying HGG patients into prognostically distinct subgroups with differential survival trajectories following post-radiotherapy TMZ chemotherapy.

Abstract

Background

High-grade gliomas (HGGs) exhibit marked intratumoral heterogeneity, which is associated with variable survival outcomes among patients receiving standard adjuvant chemotherapy. Conventional methods relying on molecular biomarkers are constrained by technical limitations and tumor heterogeneity. This study aimed to develop a multi-channel 2.5D deep learning framework that integrates Convolutional Neural Network (CNN) and Vision Transformer (ViT) features to noninvasively stratify HGG patients based on expected survival outcomes following postoperative adjuvant temozolomide (TMZ) chemotherapy and to explore the underlying molecular mechanisms.

Methods

Multicenter MRI data (T1-CE/T2-FLAIR; n=507) were analyzed using habitat clustering to define tumor subregions. A 2.5D multi-channel strategy was employed to extract features via ResNeXt101_32 × 8d (CNN) and ViT, which were then integrated using a Transformer fusion model. Transcriptomic analyses, including differential expression, gene set enrichment analysis (GSEA), and protein-protein interaction (PPI) network analysis, were performed to biologically validate the imaging-based predictions. Model performance was assessed by the area under the curve (AUC), accuracy, sensitivity, specificity, and survival analysis (Kaplan-Meier/log-rank test).

Results

The fusion model demonstrated superior performance, consistently outperforming both CNN and ViT models across training (AUC = 0.950, 95% CI: 0.917-0.982), internal-test (0.828, 0.720-0.937), and external-validation (0.810, 0.710-0.911) cohorts. Transcriptomic validation confirmed significant enrichment of cell cycle and DNA damage response pathways in the low-risk patient group, with CHEK1, CDK1, and FEN1 identified as key regulatory genes.

Conclusion

This approach demonstrates robust, non-invasive performance in stratifying HGG patients into prognostically distinct subgroups with differential survival trajectories following post-radiotherapy TMZ chemotherapy. The association with DNA damage response pathways provides biological interpretability, supporting prognostic risk stratification and providing a reference for postoperative surveillance planning.

Read PDF

Similar papers

Open access Oct 2026

Pathology-guided multimodal transformer predicts postoperative survival benefit from adjuvant chemotherapy in glioma: from DNA damage repair to immune characterization

This model identifies patients unlikely to benefit from standard TMZ chemotherapy, providing a tool for postoperative personalized treatment stratification and optimization of therapeutic strategies in HGGs.

Ze-Hui Li, Xin Duan, Jun-Jie Lian et al. · 0 citations
#small language model Open access Nov 2026

Multimodal Transformer Integrating CT and Pathology for Postoperative Risk Stratification in Stage I Non-Small Cell Lung Cancer.

The DLRTransformer improved postoperative risk stratification compared with guideline-based risk stratification and identified patients with stage I NSCLC who benefited from adjuvant therapy.

Li-Ying Wang, Yu Zong, Xin-Yu Li et al. · 0 citations
Open access Oct 2026

Multi-task deep learning integrating pretreatment MRI and whole slide images predicts induction chemotherapy response and survival in locally advanced nasopharyngeal carcinoma

Predicting response to induction chemotherapy (IC) and overall survival (OS) is critical for optimizing treatment in patients with locally advanced nasopharyngeal carcinoma (LANPC). This study aimed to develop and validate a multi-task deep learning model integrating pretreatment MRI and whole slide images (WSIs) to pr...

Jing Hou, Xiao-Chun Yi, Cong-Rui Li et al. · 0 citations
Open access Nov 2026

A deep-learning model based on histological images predicts survival and pathological response to neoadjuvant chemotherapy and chemoimmunotherapy in breast cancer

An artificial intelligence (AI)-based deep-learning model enables accurate inference of a clinically validated immune gene-expression program directly from routine H&E slides and is independently associated with survival and pCR to NACT/NACTIT in eBC.

F. Bertucci, Gwenael Lumet, Mathieu Delattre et al. · 0 citations
Sep 2026

A Transformer-Based Deep Learning Model for Prediction of Temozolomide Resistance in Glioblastoma Using Pretreatment MRI Images.

OBJECTIVE Glioblastoma (GBM) is a lethal tumor where temozolomide (TMZ) chemotherapy often faces resistance. We develop a deep learning model based on a Vision Transformer (ViT) architecture for pretreatment prediction of TMZ resistance. METHODS We retrospectively enrolled 314 GBM patients across four centers between...

Cai-Qiang Xue, Sheng-Lin Li, Yu-Feng Li et al. · 0 citations
Conference Open access Oct 2026

A Digital Twin Framework for Glioblastoma Survival Prediction Using Explainable Machine Learning and Multimodal MRI Radiomic Features

Glioblastoma multiforme (GBM)is one of the most common and lethal forms of brain tumor, with a median overall survival time of being only 12-15 months.GBM is highly heterogeneous meaning that there is considerable variation in tumor characteristics, behavior, and treatment outcomes across patients. This leads to differ...

Asima Majied Wani, M. Chishti, M. A. Wani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.